Mario Guralnik
Nessuna posizione attualmente
Profilo
Dr. Mario Guralnik is Head-US Clinical Operations at Ora Bio Ltd.
Dr. Guralnik was previously employed as a Manager-Clinical Affairs by Amgen, Inc.
He received his doctorate degree from the University of California, Los Angeles.
Precedenti posizioni note di Mario Guralnik
| Società | Posizione | Fine |
|---|---|---|
Ora Bio Ltd.
 Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Corporate Officer/Principal | - |
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Mario Guralnik
| University of California, Los Angeles | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Health Technology |
- Borsa valori
- Insiders
- Mario Guralnik
